ARENA PHARMACEUTICALS INC
10-Q, EX-27.1, 2000-09-11
PHARMACEUTICAL PREPARATIONS
Previous: ARENA PHARMACEUTICALS INC, 10-Q, 2000-09-11
Next: WATTAGE MONITOR INC, DEF 14A, 2000-09-11



<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                      31,941,743
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                            32,216,231
<PP&E>                                       3,880,226
<DEPRECIATION>                                (937,728)
<TOTAL-ASSETS>                              36,015,054
<CURRENT-LIABILITIES>                        1,771,607
<BONDS>                                              0
                       48,317,013
                                          0
<COMMON>                                           190
<OTHER-SE>                                 (17,657,698)
<TOTAL-LIABILITY-AND-EQUITY>                36,015,054
<SALES>                                              0
<TOTAL-REVENUES>                             1,289,271
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                             7,829,531
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             117,635
<INCOME-PRETAX>                             (6,008,282)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                (6,008,282)
<EPS-BASIC>                                   (23.70)
<EPS-DILUTED>                                   (23.70)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission